These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 5068262

  • 1. [Distribution of exogenous and endogenous L-asparaginase in mice].
    Wierer U, Pütter J.
    Arzneimittelforschung; 1972 Apr; 22(4):791-5. PubMed ID: 5068262
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic behavior of L-asparaginase in men and in animals.
    Pütter J.
    Recent Results Cancer Res; 1970 Apr; 33():64-74. PubMed ID: 5526349
    [No Abstract] [Full Text] [Related]

  • 3. Basis for loss of therapeutic effectiveness of L-asparaginase in sensitized mice.
    Baechtel S, Prager MD.
    Cancer Res; 1973 Aug; 33(8):1966-9. PubMed ID: 4578567
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of lymphoma 6C3HED by L-asparaginase from Serratia marcescens.
    Boyd JW, Phillips AW.
    J Natl Cancer Inst; 1971 Jun; 46(6):1271-6. PubMed ID: 4932428
    [No Abstract] [Full Text] [Related]

  • 5. In vivo effects of intraperitoneally injected L-asparaginase solution and L-asparaginase immobilized within semipermeable nylon microcapsules with emphasis on blood L-asparaginase, 'body' L-asparaginase, and plasma L-asparagine levels.
    Siu Chong ED, Chang TM.
    Enzyme; 1974 Jun; 18(3):218-39. PubMed ID: 4601662
    [No Abstract] [Full Text] [Related]

  • 6. Transaminations of amino donors with alpha-ketoglutarate in normal and neoplastic mouse tissues measured by a simple radiometric procedure.
    Simonsen DG, Roberts E.
    Biochem Med; 1974 May; 10(1):36-49. PubMed ID: 4597326
    [No Abstract] [Full Text] [Related]

  • 7. Asparagine synthetase in normal and malignant tissues: correlation with tumor sensitivity to asparaginase.
    Prager MD, Bachynsky N.
    Arch Biochem Biophys; 1968 Sep 20; 127(1):645-54. PubMed ID: 4880551
    [No Abstract] [Full Text] [Related]

  • 8. [The antitumor activity of L-asparaginase].
    Adamson RH, Fabro S.
    Acta Vitaminol Enzymol; 1969 Sep 20; 23(3):111-24. PubMed ID: 4897937
    [No Abstract] [Full Text] [Related]

  • 9. [Study of glutaminase and asparaginase activities in normal tissues and malignant tumors].
    Berezov TT.
    Ukr Biokhim Zh; 1966 Sep 20; 38(5):484-9. PubMed ID: 4298788
    [No Abstract] [Full Text] [Related]

  • 10. [Inhibition of the succino-dehydrogenase of animal tumors and normal tissues by 4-hydroxypentenal].
    Kapfer E, Schauenstein E.
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972 Sep 20; 77(3):180-8. PubMed ID: 4262172
    [No Abstract] [Full Text] [Related]

  • 11. [Absorption in vitro, by malignant cells, of serum proteins of rabbits and agoutis (l-asparaginase) conjugated with fluorescent substances].
    Wanick LR.
    Rev Inst Antibiot (Recife); 1971 Jun 20; 11(1):39-42. PubMed ID: 5161610
    [No Abstract] [Full Text] [Related]

  • 12. Effect of a basic liver protein fraction on KB and Ehrlich ascites tumor cells.
    Comoroşan S, Stănescu M, Solomon S, Gaşpar A, Vieru S, Sandru D, Soldatu M.
    Arch Geschwulstforsch; 1967 Jun 20; 28(4):320-7. PubMed ID: 5594755
    [No Abstract] [Full Text] [Related]

  • 13. Metabolism of proteins and glycoproteins in tumour bearing mice treated with Aeromonas L-asparaginase.
    Benny PJ, Muraleedhara KG, Sreejith K, Jayashree G.
    Indian J Biochem Biophys; 1996 Dec 20; 33(6):527-30. PubMed ID: 9219441
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy of animal tumors with L-asparaginase and antagonists of glutamine or glutamic acid.
    Tarnowski GS, Mountain IM, Stock CC.
    Cancer Res; 1970 Apr 20; 30(4):1118-22. PubMed ID: 5504351
    [No Abstract] [Full Text] [Related]

  • 15. Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors.
    Broome JD.
    Br J Cancer; 1968 Sep 20; 22(3):595-602. PubMed ID: 4878639
    [No Abstract] [Full Text] [Related]

  • 16. L-glutamine:D-fructose 6-phosphate amidotransferase in tumors and the liver of tumor-bearing animals.
    Kikuchi H, Kobayashi Y, Tsuiki S.
    Biochim Biophys Acta; 1971 Jun 22; 237(3):412-21. PubMed ID: 4330266
    [No Abstract] [Full Text] [Related]

  • 17. [Experimental results in radiochemotherapy using L-asparaginase].
    Ringleb D, Billger J, Busch E, Haeger V, Jung A, Kratz L.
    Fortschr Geb Rontgenstr Nuklearmed; 1972 Jun 22; ():Suppl:192-3. PubMed ID: 4341092
    [No Abstract] [Full Text] [Related]

  • 18. [Experimental study of the antineoplastic activity of the antibiotic reumycin].
    Navashin SM, Fomina IP, Koroleva VG, Terent'eva TG, Shtegal'man LA.
    Antibiotiki; 1967 Oct 22; 12(10):892-8. PubMed ID: 5631328
    [No Abstract] [Full Text] [Related]

  • 19. A factor responsible for the metabolic deviations in liver of tumor-bearing animals.
    Tanaka T, Yanagi S, Miyahara M, Kaku R, Imamura K.
    Gan; 1972 Oct 22; 63(5):555-62. PubMed ID: 4645275
    [No Abstract] [Full Text] [Related]

  • 20. 51 Cr-L-asparagine accumulation by tumors: the influence of L-asparaginase treatment.
    Anghileri LJ.
    J Nucl Biol Med; 1970 Oct 22; 14(4):150-2. PubMed ID: 5538035
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.